.
MergerLinks Header Logo

Announced

Multiples-led consortium to acquire a 9.3% stake in BDR Pharmaceuticals for $91m.

Financials

Edit Data
Transaction Value£74m
Consideration TypeCash
Capital Owned-
Capital Bid For9%
EV/Sales-
EV/EBITDA-
Share Price Premium-
One Off Charge-

Sources

Edit

Tags

Edit

Minority

Pharmaceuticals

Private

Acquisition

Domestic

India

pharmaceutical company

Private Equity

Pending

Friendly

Synopsis

Edit

Multiples, a private equity firm, Times Group, a media conglomerate, QRG Invest, Nishant Agarwal and Mallika Srinivasan agreed to acquire a 9.3% stake in BDR Pharmaceuticals, a pharmaceutical company, for $91m. "It is our pleasure to partner Multiples, as our first PE investor. Multiples is an active investor in the pharmaceuticals sector and have a strong track record of partnering with visionary entrepreneurs and management teams in helping them in their transformation journeys,” Dharmesh Shah, BDR Pharmaceuticals Chairman and Managing Director.

© COPYRIGHT 2024 MERGERLINKS LIMITED.

ALL RIGHTS RESERVED.

15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.

CONTACT US